The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C

British Journal of Pharmacology
S Hamid-BloomfieldB J Whittle

Abstract

1. In anaesthetized, pump-ventilated guinea-pigs, bolus intravenous injection of prostaglandin D2 (PGD2 5-160 micrograms kg-1) caused a dose-dependent rise in both heart rate and systemic mean arterial blood pressure with only a small monophasic rise in pulmonary inflation pressure (PIP). 2. In contrast, inhaled PGD2 (0.1-1 mg ml-1, 30s) provoked a substantial concentration-dependent biphasic rise in PIP. The bronchoconstrictor action of inhaled PGD2 was accompanied by minimal cardiovascular effects. 3. The 3-benzyl substituted hydantoin BW A868C (0.1-1 mg kg-1 i.v.) a novel prostanoid DP-receptor antagonist, had no significant effect on the cardiovascular or bronchoconstrictor effects of intravenously administered or inhaled PGD2. 4. However, BW A868C (0.1-1 mg kg-1 i.v.) did inhibit the hypotensive actions of the DP-receptor agonist, BW 245C (1-3 micrograms kg-1 i.v.). 5. The prostanoid TP-receptor antagonist BM 13.177 (2.5 mg kg-1 i.v.) strongly inhibited the bronchoconstrictor effect of inhaled PGD2, abolishing the first phase of this response and reducing the peak increase in PIP provoked by PGD2 (0.1 or 1 mg ml-1 for 30 s), by 67 +/- 16% and 44 +/- 5% respectively. 6. A combination of BW A868C (0.1 or 1 mg kg-1 i.v.) with...Continue Reading

References

Mar 1, 1978·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·E W SpannhakeP J Kadowitz
Feb 1, 1977·Prostaglandins·M A WassermanF G Robinson
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·C RobinsonS T Holgate
May 1, 1985·British Journal of Pharmacology·M J FinneyC G Persson
Feb 1, 1989·British Journal of Pharmacology·D G TristA D Robertson
Apr 1, 1989·Journal of Applied Physiology·R C BeasleyS T Holgate
Feb 1, 1989·British Journal of Pharmacology·S Hamid-Bloomfield, B J Whittle
Mar 1, 1989·British Journal of Pharmacology·R A Coleman, R L Sheldrick
Aug 1, 1986·British Journal of Pharmacology·S Hamid-Bloomfield, B J Whittle
Jun 1, 1988·British Journal of Pharmacology·R M Eglen, R L Whiting
Feb 1, 1988·Prostaglandins·H Giles, P Leff
Mar 1, 1988·Journal of Medicinal Chemistry·W P JacksonP J Wates
Sep 25, 1986·The New England Journal of Medicine·J J MurrayJ A Oates
Mar 1, 1987·Journal of Pharmacological Methods·A N Payne, G de Nucci
Jul 26, 1984·The New England Journal of Medicine·C C HardyS T Holgate
Dec 1, 1984·Prostaglandins·D J HeaveyC T Dollery
Apr 1, 1980·The Journal of Allergy and Clinical Immunology·R PattersonP A Greenberger
Dec 1, 1981·Prostaglandins·E W SpannhakeP J Kadowitz

❮ Previous
Next ❯

Citations

Sep 1, 1991·Medicinal Research Reviews·S E Hall
Jan 19, 1993·European Journal of Pharmacology·D F WoodwardA L Nieves
Mar 14, 1995·European Journal of Pharmacology·T MatsugiE Shirasawa
Apr 29, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Najam A SharifGary W Williams
Jan 1, 1997·Fundamental & Clinical Pharmacology·P Devillier, G Bessard
Aug 31, 2006·International Archives of Allergy and Immunology·Takahito ChibaJunichi Chihara
Aug 9, 2007·International Archives of Allergy and Immunology·Takahito ChibaJunichi Chihara
Jan 25, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Y ShiraishiE W Gelfand
Oct 18, 2006·Journal of Leukocyte Biology·Hilary SandigIan Sabroe
Nov 6, 2004·The Journal of Pharmacology and Experimental Therapeutics·Yoshiki ShiraishiAkitoshi Ishizaka
Aug 11, 1995·The Journal of Biological Chemistry·Y BoieM Abramovitz
Aug 5, 2017·Frontiers in Medicine·Miriam PeinhauptAkos Heinemann
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Petra SchratlAkos Heinemann
Aug 1, 1995·Prostaglandins, Leukotrienes, and Essential Fatty Acids·H NagaiN Inagaki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.